Satoshi Kubo - Concepedia

Author

Satoshi Kubo

University of Occupational and Environmental Health Japan ORCID

Also Known As

Kubo, S., Kubo, Satoshi, Pascal Roblot, S KUBO, S Kubo, S. KUBO, S. Kubo, S. Kubo, SATOSHI KUBO, Satoshi KUBO

302

Publications

6.9K

Citations

H-Index

105

Concepts

All Affiliations

University of Occupational and Environmental Health Japan Keio University Hiroshima University National Institutes of Health National Institute of Allergy and Infectious Diseases

About

Satoshi Kubo is an author at University of Occupational and Environmental Health Japan specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.1K
2	Cell Biology	7	7	454
3	Public Health	4	4	133
4	Allergy	1	1	27
5	Cellular Physiology	1	1	54

Satoshi Kubo

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells Keisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo, Arthritis & Rheumatism	2011	224
Mucus sialylation determines intestinal host-commensal homeostasis Yikun Yao, Girak Kim, Samantha Shafer, Cell Mucosal ImmunologyMucus SialylationPathogenesisImmunologyGastroenterology	2022	211
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo, Annals of the Rheumatic Diseases	2013	187
The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells Satoshi Kubo, Kunihiro Yamaoka, Masahiro Kondo, Annals of the Rheumatic Diseases	2013	166
Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System Satoshi Kubo, Shingo Nakayamada, Kei Sakata, Frontiers in Immunology Jak/stat SignalingAdaptive Immune SystemCellular ImmunologyImmunologyImmune Regulation	2018	132
Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis Ippei Miyagawa, Shingo Nakayamada, Kazuhisa Nakano, Lara D. Veeken	2018	113
Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors Xiaoxue Ma, Shingo Nakayamada, Satoshi Kubo, Annals of the Rheumatic Diseases	2018	109
Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients Satoshi Kubo, Shingo Nakayamada, Maiko Yoshikawa, Arthritis & Rheumatology	2017	99
Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis Shingo Nakayamada, Satoshi Kubo, Maiko Yoshikawa, Lara D. Veeken	2017	98
T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. Chrong‐Reen Wang, Kohei Hashimoto, Satoshi Kubo, The Journal of Experimental Medicine T-regulatory CellImmunologyImmune RegulationImmunologic MechanismCd4 T Cell Responses	1995	94

Page 1